The Anti-tumorigenic Properties of Peroxisomal Proliferator-activated Receptor α Are Arachidonic Acid Epoxygenase-mediated

The arachidonic acid epoxygenase is a component of the signaling mechanisms responsible for VEGF-stimulated angiogenesis

(2009) Shiling Yang et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Vascular Endothelial Growth Factor Pathway—Targeted Therapy as Initial Systemic Treatment of Patients with Renal Cancer

(2009) Elizabeth K. Chung et al.   Clinical Genitourinary Cancer

Epoxyeicosatrienoic acids are part of the VEGF-activated signaling cascade leading to angiogenesis

(2008) Anke C. Webler et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

In situ molecular imaging of proteins in tissues using mass spectrometry

(2008) William M. Hardesty et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

An essential role for SRC-activated STAT-3 in 14,15-EET-induced VEGF expression and angiogenesis

(2008) S. Y. Cheranov et al.   BLOOD

Peroxisome proliferator-activated receptor-alpha (PPARA) genetic polymorphisms and breast cancer risk: a Long Island ancillary study

(2008) A. K. Golembesky et al.   CARCINOGENESIS

Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?

(2008) Alexander Tenenbaum et al.   Cardiovascular Diabetology

Tumor Escape from Endogenous, Extracellular Matrix-Associated Angiogenesis Inhibitors by Up-Regulation of Multiple Proangiogenic Factors

(2008) N. T. Fernando et al.   CLINICAL CANCER RESEARCH

Peroxisome Proliferator-Activated Receptor   Pathway Targeting in Carcinogenesis: Implications for Chemoprevention

(2008) F. Ondrey   CLINICAL CANCER RESEARCH

Activation of PPARα inhibits IGF‐I‐mediated growth and survival responses in medulloblastoma cell lines

(2008) Katarzyna Urbanska et al.   INTERNATIONAL JOURNAL OF CANCER

Lethality in an anti-angiogenic tumor gene therapy model upon constitutive but not inducible expression of the soluble vascular endothelial growth factor receptor 1

(2008) Vijayshankar Ganesh Sivanandam et al.   JOURNAL OF GENE MEDICINE

Complete clinical remission of tumor-stage mycosis fungoides after acute extensive skin necroses, granulomatous reaction, and fever under treatment with bexarotene, vorinostat, and high-dose fenofibrate

(2008) Matthias Steinhoff et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The Case ∣ Progressive hypertension and proteinuria on anti-angiogenic therapy

(2008) Jagdeep S. Obhrai et al.   KIDNEY INTERNATIONAL

PPAR  agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition

(2008) D. Panigrahy et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

PPARαLigands as Antitumorigenic and Antiangiogenic Agents

(2008) Ambra Pozzi et al.   PPAR Research

PPARα: Mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators

(2007) Frank J. Gonzalez et al.   TOXICOLOGY